Literature DB >> 1222393

Chemotherapy of transplanted adenocarcinomas of the colon in mice.

J A Double, C R Ball.   

Abstract

Transplantable adenocarcinomas of the colon in mice have been developed from primary tumors induced by 1,2-dimethylhydrazine. Two such transplant lines, MAC-13 and MAC-15, have been used to assess the possible value of this type of tumor in chemotherapy screening. A protocol has been established and 11 standard drugs were tested against the two lines. Both tumors show sensitivity which is remarkably similar to that of human large bowel cancer, and MAC-13 would have correctly predicted the activity in man for ten of the 11 drugs. Quantitatively, CCNU, methyl-CCNU, and cyclophamide were the most effective drugs. A comparison of the predictive efficiencies of L1210 leukemia, B16 melanoma, and these new tumors as screening systems for colorectal cancer is made and discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1222393

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


  17 in total

1.  Influence of the tissue distribution of ThioTEPA and its metabolite, TEPA, on the response of murine colon tumours.

Authors:  M C Bibby; B J McDermott; J A Double; R M Phillips; P M Loadman; L Burgess
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 2.  Muscle alterations in the development and progression of cancer-induced muscle atrophy: a review.

Authors:  Megan E Rosa-Caldwell; Dennis K Fix; Tyrone A Washington; Nicholas P Greene
Journal:  J Appl Physiol (1985)       Date:  2019-11-14

3.  Activity of N-[N'-(2-chloroethyl)-N'-nitrosocarbamoyl]-alanine and derivatives against transplantable adenocarcinomata of the mouse colon (MAC).

Authors:  M C Bibby; J A Double
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

4.  The assessment of response of murine transplantable colon tumors to combination chemotherapy.

Authors:  D M Cowen; J Siegerstetter; A C Janik; J A Double
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

5.  Cytofluorescence localization of adriamycin in resistant colon cancer cells.

Authors:  B Chauffert; F Martin; A Caignard; J F Jeannin; A Leclerc
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

6.  The effect of chemotherapy on occult metastases after surgical removal of a non-immunogenic mouse carcinoma.

Authors:  T Zebro; E A Wright
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

7.  Experimental correlations of in vitro drug sensitivity with in vivo responses to ThioTEPA in a panel of murine colon tumours.

Authors:  R M Phillips; M C Bibby; J A Double
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

8.  Twenty-ninth annual meeting of the British Association for Cancer Research in conjunction with the third annual meeting of the Association of Cancer Physicians. March 21-24, 1988, Norwich, U.K. Abstracts.

Authors: 
Journal:  Br J Cancer       Date:  1988-08       Impact factor: 7.640

9.  The logistics of broader pre-clinical evaluation of potential anti-cancer agents with reference to anti-tumour activity and toxicity of mitozolomide.

Authors:  M C Bibby; J A Double; I A Wahed; N Hirbawi; T G Baker
Journal:  Br J Cancer       Date:  1988-08       Impact factor: 7.640

10.  The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours.

Authors:  P K Quinn; M C Bibby; J A Cox; S M Crawford
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.